Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.62 USD | -4.58% | +1.08% | -44.52% |
14/05 | Editas Medicine Insider Bought Shares Worth $253,868, According to a Recent SEC Filing | MT |
09/05 | Barclays Adjusts Editas Medicine Price Target to $9 From $11, Maintains Equal Weight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.52% | 484M | |
+33.63% | 50.85B | |
-0.09% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+11.18% | 26.11B | |
-21.95% | 19.13B | |
+8.61% | 13.05B | |
+28.31% | 12.16B | |
+24.73% | 12.08B |
- Stock Market
- Equities
- EDIT Stock
- News Editas Medicine, Inc.
- Morgan Stanley Adjusts Editas Medicine's Price Target to $7 From $8, Keeps Underweight Rating